Change in Tumor Size by RECIST Correlates Linearly With Overall Survival in Phase I Oncology Studies

PURPOSE: RECIST is used to quantify tumor changes during exposure to anticancer agents. Responses are categorized as complete response (CR), partial response (PR), stable disease (SD), or progressive disease (PD). Clinical trials dictate a patient's management options based on the category into...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Jain, Rajul K., Lee, J. Jack, Ng, Chaan, Hong, David, Gong, Jing, Naing, Aung, Wheler, Jennifer, Kurzrock, Razelle
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2012
Konular:
Original Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3413279/
https://ncbi.nlm.nih.gov/pubmed/22689801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.36.4752
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller